Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma C Morris

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|September 21, 2021
Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignanciesThomas A Fox, Amy A Kirkwood, Louise Enfield, et al.
British Journal of Haematology|July 18, 2020
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapyThomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.
British Journal of Haematology|October 26, 2020
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'Thomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.
Nature Immunology|August 23, 2022
Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulationAlan Kennedy, Erin Waters, Behzad Rowshanravan, et al.
Journal of Clinical Immunology|September 29, 2021
Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHDDanielle E Arnold, Rofida Nofal, Connor Wakefield, et al.
Blood|July 19, 2017
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adultEmma C Morris, Thomas Fox, Ronjon Chakraverty, et al.
British Journal of Haematology|August 10, 2019
Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemiaRob S Sellar, Varun Mehra, Thomas A Fox, et al.
Blood|September 27, 2022
Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunityMorgane Cheminant, Thomas A Fox, Mickael Alligon, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2024
Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party studyChristo Tsilifis, Carsten Speckmann, Su Han Lum, et al.
Blood Advances|June 20, 2025
Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide studyChristo Tsilifis, Johannes Raedler, Joanna Renke, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|September 21, 2021
Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignanciesThomas A Fox, Amy A Kirkwood, Louise Enfield, et al.
British Journal of Haematology|July 18, 2020
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapyThomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.
British Journal of Haematology|October 26, 2020
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'Thomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.
Nature Immunology|August 23, 2022
Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulationAlan Kennedy, Erin Waters, Behzad Rowshanravan, et al.
Journal of Clinical Immunology|September 29, 2021
Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHDDanielle E Arnold, Rofida Nofal, Connor Wakefield, et al.
Blood|July 19, 2017
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adultEmma C Morris, Thomas Fox, Ronjon Chakraverty, et al.
British Journal of Haematology|August 10, 2019
Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemiaRob S Sellar, Varun Mehra, Thomas A Fox, et al.
Blood|September 27, 2022
Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunityMorgane Cheminant, Thomas A Fox, Mickael Alligon, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2024
Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party studyChristo Tsilifis, Carsten Speckmann, Su Han Lum, et al.
Blood Advances|June 20, 2025
Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide studyChristo Tsilifis, Johannes Raedler, Joanna Renke, et al.
Pageof 8